Trastuzumab: Powder for I.V. infusion 150 mg, Powder for I.V. infusion 440 mg with diluent; Ogivri® Page last updated: 5 July 2019 Public Summary Document (PSD) March 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) March 2019 PBAC Meeting - (Word 181KB)